Buy ProQuad 20000 [TCID_50]/.5mL Measles, Mumps, Rubella and Varicella Virus Vaccine Live

ProQuad is a live virus vaccine for measles, mumps, rubella, and varicella. It is designed to protect against these common childhood illnesses. This lyophilized injection is suitable for subcutaneous administration.

Strength

20000 [TCID_50]/.5mL

Pack Size

10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4171-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4171-01)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

ProQuad is used to prevent measles, mumps, rubella, and varicella (chickenpox). This vaccine is typically administered to children to help build immunity against these viruses. It is often used as part of a routine vaccination schedule to ensure long-term protection.

Side Effects

Common effects of ProQuad may include mild redness, swelling, or soreness at the injection site. Some individuals may experience low-grade fever, fatigue, or mild rash. These effects are usually temporary and resolve on their own.

Precautions & Warnings

ProQuad should be handled with care and stored as directed. It is important to inform healthcare providers about any allergies or medical conditions before administration. Follow the recommended guidelines for safe handling and disposal.

Avoid Interactions

ProQuad may interact with certain medications, including immunosuppressants or other live vaccines. It is advisable to consult a healthcare provider before using ProQuad with other treatments. Avoid alcohol and other substances that may affect immune response.

References

Frequently Asked Questions

ProQuad is used to prevent measles, mumps, rubella, and varicella (chickenpox). It is typically administered to children as part of a routine vaccination schedule.

ProQuad is administered as a subcutaneous injection. It comes in a lyophilized form that needs to be reconstituted before use.

Common side effects may include mild redness, swelling, or soreness at the injection site, low-grade fever, fatigue, or a mild rash.

ProQuad may interact with other live vaccines. It is important to consult a healthcare provider before combining it with other treatments.

Individuals with severe allergies to any component of the vaccine or those with weakened immune systems should avoid ProQuad unless advised otherwise by a healthcare provider.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.